Focusing on the development and industrialization of nucleic acid medicines
Possesses a proprietary RNA-based Therapeutic Platform (RTP) independently developed for nucleic acid medicines
Grow to be a leading RNA-based pharmaceutical company
Build the world's leading nucleic acid delivery platform
